This study is looking at the safety and how the body handles a new naltrexone implant, called BICX104. Naltrexone is a medicine used to treat addiction. The study compares BICX104, with or without another medicine called bupropion, to an existing naltrexone injection called Vivitrol. Researchers want to see how much of the medicine gets into your body (Cmax, Tmax, AUC) and how long it stays there. You can join if you are a healthy adult male or female between 18 and 65 years old. The study aims to enroll 30 healthy volunteers and will follow participants for about 28 weeks.

Study design

This interventional study plans to enroll 30 healthy adult volunteers. Participants will be divided into 4 groups and receive different treatments.

What's involved

You would be followed for a total of 196 days, which includes a treatment period, a follow-up period, and a post-treatment follow-up period.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 196 days, including an 84-day treatment period, an 84-day follow-up period, and a 28-day post-treatment follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.